All In MedTech

FDA Clearance Tracker · K102011

ECLIPSE TREATMENT PLANNING SYSTEM

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Sep 3, 2010 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K102011
Device name
ECLIPSE TREATMENT PLANNING SYSTEM
Applicant location
Palo Alto, CA
Received
Jul 16, 2010
Decided
Sep 3, 2010
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 892.5050

Every decision under product code MUJ

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MUJ. The earliest in FDA's data is K915691, decided Feb 16, 1995.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Varian Medical Systems, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.